Evaluation of Clinical Efficacy of New Medical Treatments in Advanced Colorectal Cancer. Results of a Workshop Organized by the Eortc Gitccg-Reference-Cited by-同舟云学术

Evaluation of Clinical Efficacy of New Medical Treatments in Advanced Colorectal Cancer. Results of a Workshop Organized by the Eortc Gitccg

Published:1998-05 Issue:3 Volume:84 Page:335-347
ISSN:0300-8916
Container-title:Tumori Journal
language:en
Short-container-title:Tumori

Author:

Wils Jacques¹,Sahmoud Tarek²,Sobrero Alberto³,Bleiberg Harry⁴,Ahmedzai Sam⁵,Blazeby Jane⁶,Blijham Geert⁷,Conroy Thierry⁸,Cunningham David⁹,Curran Desmond²,Díaz-Rubio Eduardo¹⁰,Ducreux Michel¹¹,Evans Jeff¹²,Glimelius Bengt¹³,Hutchinson Gillian¹⁴,Kerr David¹⁵,Kiebert Gwendoline²,Köhne Hennig¹⁶,Labianca Roberto¹⁷,Langendijk Rina¹,Nitti Donato¹⁸,Nordlinger Bernard¹⁹,Rougier Philippe¹⁹,Scheithauer Werner²⁰,Schmoll Hans-Joachim²¹,Van Cutsem Eric²²,Wagener Theo²³,Wilke Jochen²⁴,Marinus Ann²,Therasse Patrick²

Affiliation:

1. St Laurentius Ziekenhuis, Roermond, The Netherlands

2. EORTC, Brussels (present address: Zeneca Medical Department, Destelbergen, Belgium), Belgium

3. Medical Oncology, University of Udine, Italy

4. Institut Jules Bordet, Brussels, Belgium

5. University of Sheffield, Sheffield, United Kingdom

6. Bristol Royal Infirmary, Bristol, United Kingdom

7. A.Z. Utrecht, Utrecht, The Netherlands

8. Centre Alexis Vautrin, Vandoeuvre-Les Nancy, France

9. Royal Marsden Hospital, Surrey, United Kingdom

10. Hospital Universitario “San Carlos”, Madrid, Spain

11. Institut Gustave Roussy, Paris, France

12. Western Infirmary, Glasgow, Scotland

13. University Hospital Uppsala, Uppsala, Sweden

14. St. George's Hospital, London, United Kingdom

15. Queen Elisabeth Medical Center, Birmingham, United Kingdom

16. Robert Rössle Klinik, Berlin, Germany

17. Ospedali Riuniti, Bergamo, Italy

18. Università di Padova, Padova, Italy

19. Hôpital Ambroise Paré, Boulogne, Paris, France

20. Allgemeines Krankenhaus Wien, Vienna, Austria

21. Martin Luther Universität, Halle, Germany

22. A.Z. Gasthuisberg, Leuven, Belgium

23. St. Radboud University Hospital, Nijmegen, The Netherlands

24. Klinikum Essen-Mitte, Essen, Germany

Abstract

During the last few years several factors have contributed to an increasing change in the medical treatment of advanced colorectal cancer. Among them are the more general acceptance of the impact of chemotherapy on quality of life and survival in first as well as in second-line treatment, the introduction of new drugs and the definition of novel endpoints which can roughly be defined as “patient benefit”. For this reason the European Organization for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Cooperative Group (GITCCG) felt it was appropriate to organize a workshop with experts from different countries and national groups to discuss in depth several aspects concerning the treatment of patients with advanced colorectal cancer.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/030089169808400306

Reference78 articles.

1. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

2. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.

3. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases

4. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance;World Journal of Gastrointestinal Oncology;2024-09-15

2. Synergistic anti-cancer effect of pristimerin and docetaxel on human colorectal HCT-116 cells;Synergy;2020-12

3. A case of fatal cetuximab-induced interstitial lung disease during the first weeks of treatment;Targeted Oncology;2013-10-10

4. Health-related quality of life as a valid outcome in the treatment of advanced colorectal cancer;European Journal of Surgical Oncology (EJSO);2007-12

5. Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: A proposal for standardization of patient characteristic reporting and stratification;Annals of Oncology;2007-10